Abstract

The Facilitates Chromatin Transcription (FACT) chromatin remodeling complex, comprised of two subunits, SSRP1 and SPT16, is involved in transcription, replication and DNA repair. We recently showed that curaxins, small molecules with anti-cancer activity, target FACT and kill tumor cells in a FACT-dependent manner. We also found that FACT is overexpressed in human and mouse tumors and that tumor cells are sensitive to FACT downregulation. To clarify the clinical potential of FACT inhibition, we were interested in physiological role(s) of FACT in multicellular organisms. We analyzed SSRP1 and SPT16 expression in different cells, tissues and conditions using Immunohistochemical (IHC) staining of mouse and human tissues and analysis of publically available high-content gene expression datasets. Both approaches demonstrated coordinated expression of the two FACT subunits, which was primarily associated with the stage of cellular differentiation. Most cells of adult tissues do not have detectable protein level of FACT. High FACT expression was associated with stem or less-differentiated cells, while low FACT levels were seen in more differentiated cells. Experimental manipulation of cell differentiation and proliferation in vitro, as well as tissue staining for the Ki67 proliferation marker, showed that FACT expression is related more to differentiation than to proliferation. Thus, FACT may be part of a stem cell-like gene expression signature and play a role in maintaining cells in an undifferentiated state, which is consistent with its potential role as an anti-cancer target.

Highlights

  • FACT (Facilitates Chromatin Transcription) is a chromatin remodeling complex composed of two subunits, Structure Specific Recognition Protein 1 (SSRP1) and Suppressor of Ty 16 (SPT16)

  • Expression of the SSRP1 and SPT16 subunits of FACT was studied by immunohistochemistry in normal tissues of adult mice (FVB, 8-12 weeks old, male and female) and humans (control non-cancerous tissues from cancer patient on tumor tissue microarrays (TMA) provided by RPCI Pathology Network Recourse)

  • Www.impactjournals.com/oncotarget the pattern of SSRP1 and SPT16 expression was similar between mouse and human tissues of both genders

Read more

Summary

Introduction

FACT (Facilitates Chromatin Transcription) is a chromatin remodeling complex composed of two subunits, Structure Specific Recognition Protein 1 (SSRP1) and Suppressor of Ty 16 (SPT16). We have identified FACT as a molecular target of a novel class of candidate anti-cancer agents named curaxins [1]. We found that expression of both FACT subunits was elevated in several types of mouse and human tumor cell lines as compared to their normal counterparts and that genetic knockdown of either FACT subunit compromised tumor cell viability [1]. These data suggest that FACT might play a role in development, maintenance or progression of cancer and, be a potential target for anti-cancer therapy via curaxins or other agents. An improved understanding of the physiological role(s) of FACT under normal conditions as well as its pattern of expression in mammals is necessary before the consequences of global FACT inhibition can be predicted and development of anti-FACT therapeutic approaches can proceed

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call